Reviewers winnowed an initial 27 assays to a group of nine that were evaluated using NCI sample sets, ultimately choosing ClearNote's Avantect and Guardant's Shield.

UCLA's Electric Field-Induced Release and Measurement (EFIRM) system could offer the early detection of cancers and other diseases through a droplet-size saliva sample.

The organization noted that US senators have introduced a bill to accelerate Medicare coverage for breakthrough devices.